By Staff
Friday, May 10, 2024 1:05 PM
Doctors and researchers are closely watching a
new COVID variant called KP.2, monitoring what its spread might mean for the Spring and Summer seasons. Head over to
The New York Times for more.
By Staff
Thursday, May 9, 2024 12:24 AM
NEW YORK—The national average for gross revenue at ECP locations decreased last week, April 29–May 5, when compared with the previous week at a rate of -1 index point. That places gross revenue at a level 3 index points above where it was at this point in time (Week 18) when compared with last year (2023), 10 points above the same period in 2022, 14 points above 2021, 93 points above 2020 (during COVID) and 23 points above 2019, according to Jobson’s most recent Practice Performance Tracker.
By Staff
Wednesday, May 8, 2024 8:02 AM
There is no association between the SARS-CoV-2 vaccine and the risk for new-onset seizure, data from a new meta-analysis of six randomized, placebo-controlled clinical trials (RCTs) showed.
By Staff
Tuesday, May 7, 2024 6:09 AM
Thousands of Americans believe they suffered legitimate injuries from COVID vaccines but say they've been ignored and dismissed. Click
here to read the full story.
By Staff
Monday, May 6, 2024 6:09 AM
The World Health Organization has issued a report that transforms how the world understands respiratory infections like covid-19, influenza, and measles.
By Staff
Friday, May 3, 2024 6:09 AM
SARS-CoV-2 viral loads were sharply decreased with metformin, according to a placebo-controlled trial. Click
here to read the full story.
By Staff
Friday, May 3, 2024 6:02 AM
BERLIN—To date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many other potential applications for this vaccine technology, which suggests a promising future. Martina Prelog, MD, a pediatric and adolescent medicine specialist at the University Hospital of Würzburg in Germany, reported on the principles, research status, and perspectives for these vaccines at the 25th Travel and Health Forum of the Center for Travel Medicine in Berlin.
By Staff
Friday, May 3, 2024 12:27 AM
NEW YORK—The national average for gross revenue at ECP locations decreased last week, April 22–28, when compared with the previous week at a rate of -2 index points. That places gross revenue at a level 5 index points above where it was at this point in time (Week 17) when compared with last year (2023), 11 points above the same period in 2022, 14 points above 2021, 102 points above 2020 (during COVID) and 19 points above 2019, according to Jobson’s most recent Practice Performance Tracker.
By Staff
Thursday, May 2, 2024 8:02 AM
In the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed about half that amount. Yet half as many people received the updated COVID booster as those who got the flu shot—even though COVID is twice as deadly as influenza.
By Staff
Wednesday, May 1, 2024 6:09 AM
The incidence of
new-onset seizures was not significantly different between SARS-CoV-2 vaccine recipients and placebo recipients, a meta-analysis of clinical trial data showed, according to
JAMA Neurology.
By Staff
Wednesday, May 1, 2024 6:09 AM
The appearance of virology researcher Peter Daszak, PhD, whose organization worked with the Wuhan Institute of Virology (WIV) to study bat coronaviruses, drew the expected tough questions from House Republicans at a hearing Wednesday, but Democrats weren't letting Daszak off the hook either.
By Staff
Friday, April 26, 2024 8:02 AM
A recent study recorded long COVID was more prevalent in men with type 2 diabetes (T2D) than in matched non-T2D control individuals, whereas the opposite was seen for women with T2D. Overall recorded long COVID rates were similar for men and women with T2D. Younger age, female sex, mixed ethnicity and higher body mass index (BMI) were all associated with a greater likelihood of developing long COVID.
By Staff
Friday, April 26, 2024 6:09 AM
Only myocarditis/pericarditis and seizures occurred at higher rates in adolescents and children vaccinated for COVID-19 when compared with historical rates of those outcomes, according to an analysis of safety data from the FDA's Biologics Effectiveness and Safety (BEST) Initiative.
By Staff
Thursday, April 25, 2024 6:09 AM
People with a history of uveitis were more likely to experience recurrences of the potentially dangerous eye inflammation after vaccination against COVID-19, a retrospective population-based cohort study from South Korea found.
By Staff
Thursday, April 25, 2024 12:24 AM
NEW YORK—The national average for gross revenue at ECP locations increased last week, April 15–21, when compared with the previous week at a rate of 7 index points. That places gross revenue at a level 4 index points above where it was at this point in time (Week 16) when compared with last year (2023), 17 points above the same period in 2022, 14 points above 2021, 107 points above 2020 (during COVID) and 22 points above 2019, according to Jobson’s most recent Practice Performance Tracker.